The presence of a large number of mutations, and more than 30 on its spike protein makes antibodies ineffective against the Omicron variant of Covid-19, according to a research peer-reviewed and published in the Journal of Autoimmunity. The purpose of antibodies is to recognise the virus and stop the binding, which prevents infection.
Omicron, the new variant of COVID-19, has become the dominant strain around the world. The new variant of COVID-19, which was first discovered in South Africa, is the virus's most mutated version, with over 50 changes, 30 of which are in its spike protein, allowing it to bypass vaccine-induced immunity.
An extraordinary number of mutations, particularly in the Spike (S) protein of the Omicron strain, have been linked to its high transmissibility and infectivity.
These modifications also enable it to resist pre-existing antibodies in the human body, which contributes to an increasing number of re-infections and breakthrough cases. The University of Missouri researchers wanted to learn more about the alterations detected in the Omicron variant's S-protein.
The study detected 46 hallmark changes within the Omicron variant using full sequences, 23 of which were wholly new and had not been identified in any of the previous variants of the virus. Two of the mutations were discovered in the Delta or Delta Plus variant first. Thirty of the 46 changes were found in the S-protein, while the rest were found elsewhere in the viral cell. Furthermore, the researchers employed a pre-existing S-protein structure to see if the Omicron mutations would damage the Covid-19 S-protein in the same way, rendering antibodies ineffective.
According to the paper, certain mutations cause interference on the virus's surface, preventing antibodies from adhering to it, while others result in a complete loss of interaction between the antibodies and the virus, rendering the antibodies useless against the highly modified variety. According to the researchers, this shows that pre-existing immunity (whether from vaccination or past infection) may no longer be able to give adequate protection against the Omicron form of the virus, allowing it to evade antibodies and penetrate the immune system.